Drug Trial Radar · NCT07383441
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Last checked: Nov 19, 2026Latest source record: Jun 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
718
Planned (sponsor's estimate)
Start
Jun 5, 2026
Primary completion
Jan 31, 2033
Study completion Jan 31, 2034
Sponsor
- Lead sponsor
- SWOG Cancer Research NetworkResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Feb 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, pembrolizumab, cabozantinib, and lenvatinib, to SOC immunotherapy alone in treating patients with clear cell renal cell cancer that may have spread from where it first started (primary site) to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started to other places in the body (metastatic). Studies have shown that gut health (the gut microbiome) may impact the effectiveness of immunotherapy. The microbiome includes all of the bacteria and organisms naturally found in the digestive tract. MO-03, a type of biotherapy, contains material from living organisms that may help keep the digestive tract healthy and may help to increase the effect of immunotherapy. Immunotherapy with monoclonal antibodies, such as ipilimumab, nivolumab, pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are a type of angiogenesis inhibitor and tyrosine kinase inhibitor (TKI) that block certain proteins which may help keep tumor cells from growing and may also help prevent the growth of new blood vessels that tumors need to grow. Adding MO-03 to SOC immunotherapy may be more effective than SOC immunotherapy alone in treating patients with advanced or metastatic clear cell renal cell cancer.
Conditions
- Advanced Clear Cell Renal Cell Carcinoma
- Metastatic Clear Cell Renal Cell Carcinoma
- Stage III Renal Cell Cancer AJCC v8
- Stage IV Renal Cell Cancer AJCC v8
Interventions
AxitinibDrug
Given PO
Biospecimen CollectionProcedure
Undergo blood sample collection
Bone ScanProcedure
Undergo bone scan
CabozantinibDrug
Given PO
Clostridium butyricum CBM 588 Probiotic StrainDrug
Given PO
Computed TomographyProcedure
Undergo CT
IpilimumabBiological
Given IV
LenvatinibDrug
Given PO
Magnetic Resonance ImagingProcedure
Undergo MRI
NivolumabBiological
Given IV
Nivolumab and Recombinant Human HyaluronidaseDrug
Given SC
PembrolizumabBiological
Given IV
Placebo AdministrationDrug
Given PO
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: From date of randomization to date of first documentation of progression, or death due to any cause, assessed up to 5 years
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
Highlands Oncology Group - Fayetteville
Fayetteville, Arkansas · Recruiting
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas · Recruiting
Highlands Oncology Group - Rogers
Rogers, Arkansas · Recruiting
Highlands Oncology Group
Springdale, Arkansas · Recruiting
Illinois CancerCare-Bloomington
Bloomington, Illinois · Recruiting
Illinois CancerCare-Canton
Canton, Illinois · Recruiting
Illinois CancerCare-Carthage
Carthage, Illinois · Recruiting
Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois · Recruiting
Decatur Memorial Hospital
Decatur, Illinois · Recruiting
Illinois CancerCare-Eureka
Eureka, Illinois · Recruiting
Illinois CancerCare-Galesburg
Galesburg, Illinois · Recruiting
Illinois CancerCare-Kewanee Clinic
Kewanee, Illinois · Recruiting
Illinois CancerCare-Macomb
Macomb, Illinois · Recruiting
Illinois CancerCare-Ottawa Clinic
Ottawa, Illinois · Recruiting
Illinois CancerCare-Pekin
Pekin, Illinois · Recruiting
Illinois CancerCare-Peoria
Peoria, Illinois · Recruiting
Illinois CancerCare-Peru
Peru, Illinois · Recruiting
Illinois CancerCare-Princeton
Princeton, Illinois · Recruiting
Southern Illinois University School of Medicine
Springfield, Illinois · Recruiting
Illinois CancerCare - Washington
Washington, Illinois · Recruiting
Mercy Hospital
Cedar Rapids, Iowa · Recruiting
Oncology Associates at Mercy Medical Center
Cedar Rapids, Iowa · Recruiting
Lahey Hospital and Medical Center
Burlington, Massachusetts · Recruiting
Lahey Medical Center-Peabody
Peabody, Massachusetts · Recruiting
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Brighton, Michigan · Recruiting
Trinity Health IHA Medical Group Hematology Oncology - Canton
Canton, Michigan · Recruiting
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Chelsea, Michigan · Recruiting
Trinity Health Saint Mary Mercy Livonia Hospital
Livonia, Michigan · Recruiting
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Ypsilanti, Michigan · Recruiting
Baptist Memorial Hospital and Cancer Center-Golden Triangle
Columbus, Mississippi · Recruiting
Baptist Cancer Center-Grenada
Grenada, Mississippi · Recruiting
Baptist Memorial Hospital and Cancer Center-Union County
New Albany, Mississippi · Recruiting
Baptist Memorial Hospital and Cancer Center-Oxford
Oxford, Mississippi · Recruiting
Baptist Memorial Hospital and Cancer Center-Desoto
Southhaven, Mississippi · Recruiting
Saint Francis Medical Center
Cape Girardeau, Missouri · Recruiting
Parkland Health Center - Farmington
Farmington, Missouri · Recruiting
Sainte Genevieve County Memorial Hospital
Sainte Genevieve, Missouri · Recruiting
Missouri Baptist Medical Center
St Louis, Missouri · Recruiting
Missouri Baptist Sullivan Hospital
Sullivan, Missouri · Recruiting
Baptist Memorial Hospital and Cancer Center-Collierville
Collierville, Tennessee · Recruiting
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.